DK2090583T3 - Copolymer 1-relaterede polypeptider til anvendelse som molekylvægtsmarkører og til terapeutisk anvendelse - Google Patents

Copolymer 1-relaterede polypeptider til anvendelse som molekylvægtsmarkører og til terapeutisk anvendelse

Info

Publication number: DK2090583T3
Authority: DK; Denmark
Prior art keywords: molecular weight; weight markers; copolymer; copolymers; glatiramer acetate
Prior art date: 1998-09-25

Application number

DK09004306.8T

Other languages

English (en)

Inventor

Alexander Gad

Dora Lis

Original Assignee

Yeda Res & Dev

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-09-25

Filing date

1999-09-24

Publication date

2011-09-12

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22285926&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2090583(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1999-09-24 Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev

2011-09-12 Application granted granted Critical

2011-09-12 Publication of DK2090583T3 publication Critical patent/DK2090583T3/da

Links

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Immunology (AREA)
Diabetes (AREA)
Hematology (AREA)
Molecular Biology (AREA)
Endocrinology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biomedical Technology (AREA)
Dermatology (AREA)
Physical Education & Sports Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Urology & Nephrology (AREA)
Rheumatology (AREA)
Neurology (AREA)
Biochemistry (AREA)
Neurosurgery (AREA)
Microbiology (AREA)
Ophthalmology & Optometry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Pain & Pain Management (AREA)
Transplantation (AREA)
Obesity (AREA)
Emergency Medicine (AREA)
Epidemiology (AREA)
Reproductive Health (AREA)

DK09004306.8T 1998-09-25 1999-09-24 Copolymer 1-relaterede polypeptider til anvendelse som molekylvægtsmarkører og til terapeutisk anvendelse DK2090583T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US10169398P	1998-09-25	1998-09-25
EP99949923A EP1115743B1 (en)	1998-09-25	1999-09-24	Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use

Publications (1)

Publication Number	Publication Date
DK2090583T3 true DK2090583T3 (da)	2011-09-12

Family

ID=22285926

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
DK99949923T DK1115743T3 (da)	1998-09-25	1999-09-24	Copolymer 1-relaterede polypeptider til anvendelse som molekylvægtmarkörer og til terapeutisk anvendelse
DK10171553.0T DK2239269T3 (da)	1998-09-25	1999-09-24	Anvendelse af peptider afledt af copolymer-1 som molekylvægtsmarkører
DK09004306.8T DK2090583T3 (da)	1998-09-25	1999-09-24	Copolymer 1-relaterede polypeptider til anvendelse som molekylvægtsmarkører og til terapeutisk anvendelse

Family Applications Before (2)

Application Number	Title	Priority Date	Filing Date
DK99949923T DK1115743T3 (da)	1998-09-25	1999-09-24	Copolymer 1-relaterede polypeptider til anvendelse som molekylvægtmarkörer og til terapeutisk anvendelse
DK10171553.0T DK2239269T3 (da)	1998-09-25	1999-09-24	Anvendelse af peptider afledt af copolymer-1 som molekylvægtsmarkører

Country Status (18)

Country	Link
EP (3)	EP2239269B1 (da)
JP (2)	JP4629229B2 (da)
AT (2)	ATE516297T1 (da)
AU (1)	AU757413B2 (da)
CA (2)	CA2794705C (da)
CY (3)	CY1110490T1 (da)
DE (2)	DE09004306T1 (da)
DK (3)	DK1115743T3 (da)
ES (3)	ES2369642T3 (da)
HK (3)	HK1040521A1 (da)
HU (3)	HU229289B1 (da)
IL (4)	IL142116A0 (da)
NO (2)	NO329877B1 (da)
NZ (1)	NZ511020A (da)
PT (3)	PT2239269E (da)
SI (1)	SI1115743T1 (da)
WO (1)	WO2000018794A1 (da)
ZA (1)	ZA200102269B (da)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2527760T3 (es)	1998-07-23	2015-01-29	Yeda Research And Development Co., Ltd.	Tratamiento de enfermedad de Crohn con copolímero 1 y polipéptidos
IL141021A0 (en)	1998-07-23	2002-02-10	Yeda Res & Dev	Treatment of autoimmune conditions with copolymer 1 and related copolymers
US6800287B2 (en)	1998-09-25	2004-10-05	Yeda Research And Development Co., Ltd.	Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use
ZA200206457B (en)	2000-02-18	2003-08-13	Yeda Res & Dev	Oral, nasal and pulmonary dosage formulations of copolymer 1.
US20020077278A1 (en)	2000-06-05	2002-06-20	Yong V. Wee	Use of glatiramer acetate (copolymer 1) in the treatment of central nervous system disorders
WO2002076503A1 (en)	2000-06-20	2002-10-03	Mayo Foundation For Medical Education And Research	Treatment of central nervous system diseases by antibodies against glatiramer acetate
WO2001097785A2 (en) *	2000-06-20	2001-12-27	Caprion Pharmaceuticals Inc.	Basic copolymers for the treatment of prion-related-disease
US20040037828A1 (en) *	2002-07-09	2004-02-26	Bar-Ilan University	Methods and pharmaceutical compositions for healing wounds
WO2003029276A2 (en) *	2001-10-03	2003-04-10	President And Fellows Of Harvard College	Copolymers for suppression of autoimmune diseases, and methods of use
EP1459065B1 (en)	2001-12-04	2010-07-28	Teva Pharmaceutical Industries, Ltd.	Processes for the measurement of the potency of glatiramer acetate
WO2004064717A2 (en)	2003-01-21	2004-08-05	Yeda Research And Development Co. Ltd.	Cop 1 for treatment of inflammatory bowel diseases
CN101287483B (zh)	2003-08-07	2012-02-29	希尔洛有限公司	用于加速伤口愈合的药物组合物和方法
CA2558655A1 (en) *	2004-03-01	2005-09-15	Kai W. Wucherpfennig	Methods and compositions for treatment of autoimmune diseases
US7655221B2 (en)	2004-05-07	2010-02-02	Peptimmune, Inc.	Methods of treating disease with random copolymers
US7560100B2 (en)	2004-09-09	2009-07-14	Yeda Research And Development Co., Ltd.	Mixtures of polypeptides, compositions containing and processes for preparing same, for treating neurodegenerative diseases
US7858337B2 (en) *	2007-03-08	2010-12-28	Novartis Ag	Process for the manufacture of a composite material
US8399413B2 (en)	2009-08-20	2013-03-19	Yeda Research & Development Co., Ltd.	Low frequency glatiramer acetate therapy
USRE49251E1 (en)	2010-01-04	2022-10-18	Mapi Pharma Ltd.	Depot systems comprising glatiramer or pharmacologically acceptable salt thereof
US8759302B2 (en)	2010-03-16	2014-06-24	Teva Pharmaceutical Industries, Ltd.	Methods of treating a subject afflicted with an autoimmune disease using predictive biomarkers of clinical response to glatiramer acetate therapy in multiple sclerosis
WO2012051106A1 (en)	2010-10-11	2012-04-19	Teva Pharmaceutical Industries Ltd.	Cytokine biomarkers as predictive biomarkers of clinical response for glatiramer acetate
CA2827275A1 (en)	2011-02-14	2012-09-20	Usv Limited	Copolymer-1, process for preparation and analytical methods thereof
MX2014004309A (es)	2011-10-10	2015-07-06	Teva Pharma	Polimorfismos de nucleotidos individuales utiles para predecir una respuesta clinica para el acetato de glatiramer.
TW201420111A (zh)	2012-10-10	2014-06-01	Teva Pharma	對格拉默醋酸鹽（ｇｌａｔｉｒａｍｅｒａｃｅｔａｔｅ）之臨床反應具預測性之生物標記
CN104098655B (zh) *	2013-04-09	2018-01-30	深圳翰宇药业股份有限公司	用于合成醋酸格拉替雷的质谱内标的多肽
UY35790A (es)	2013-10-21	2015-05-29	Teva Pharma	Marcadores genéticos que predicen la respuesta al acetato de glatiramer
CN105218646B (zh) *	2014-06-24	2018-09-21	深圳翰宇药业股份有限公司	一种用于检测醋酸格拉替雷样本的uplc方法
US9155775B1 (en)	2015-01-28	2015-10-13	Teva Pharmaceutical Industries, Ltd.	Process for manufacturing glatiramer acetate product
CN107531750B (zh) *	2015-04-28	2021-03-16	深圳翰宇药业股份有限公司	多肽混合物高效液相色谱分析方法
EP3147667B1 (en) *	2015-09-24	2019-06-12	CHEMI S.p.A.	Analysis of the molecular weight distribution of complex polypeptide mixtures
EP3600553A4 (en)	2017-03-26	2020-09-02	Mapi Pharma Ltd.	GLATIRAMER DEPOT SYSTEMS FOR TREATMENT OF PROGRESSIVE FORMS OF MULTIPLE SCLEROSIS

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2009996A1 (en) *	1989-02-17	1990-08-17	Kathleen S. Cook	Process for making genes encoding random polymers of amino acids
US5800808A (en)	1994-05-24	1998-09-01	Veda Research And Development Co., Ltd.	Copolymer-1 improvements in compositions of copolymers

1999
- 1999-09-24 DK DK99949923T patent/DK1115743T3/da active
- 1999-09-24 ZA ZA200102269A patent/ZA200102269B/en unknown
- 1999-09-24 PT PT101715530T patent/PT2239269E/pt unknown
- 1999-09-24 CA CA2794705A patent/CA2794705C/en not_active Expired - Lifetime
- 1999-09-24 HU HU0103889A patent/HU229289B1/hu unknown
- 1999-09-24 NZ NZ511020A patent/NZ511020A/xx not_active IP Right Cessation
- 1999-09-24 EP EP10171553A patent/EP2239269B1/en not_active Expired - Lifetime
- 1999-09-24 DK DK10171553.0T patent/DK2239269T3/da active
- 1999-09-24 JP JP2000572252A patent/JP4629229B2/ja not_active Expired - Lifetime
- 1999-09-24 DE DE09004306T patent/DE09004306T1/de active Pending
- 1999-09-24 DE DE69940888T patent/DE69940888D1/de not_active Expired - Lifetime
- 1999-09-24 AT AT09004306T patent/ATE516297T1/de active
- 1999-09-24 EP EP09004306A patent/EP2090583B1/en not_active Expired - Lifetime
- 1999-09-24 HU HU1300505A patent/HU229719B1/hu unknown
- 1999-09-24 PT PT09004306T patent/PT2090583E/pt unknown
- 1999-09-24 WO PCT/US1999/022402 patent/WO2000018794A1/en active IP Right Grant
- 1999-09-24 AT AT99949923T patent/ATE431359T1/de active
- 1999-09-24 ES ES09004306T patent/ES2369642T3/es not_active Expired - Lifetime
- 1999-09-24 PT PT99949923T patent/PT1115743E/pt unknown
- 1999-09-24 SI SI9931035T patent/SI1115743T1/sl unknown
- 1999-09-24 ES ES99949923T patent/ES2327301T3/es not_active Expired - Lifetime
- 1999-09-24 AU AU62695/99A patent/AU757413B2/en not_active Expired
- 1999-09-24 IL IL14211699A patent/IL142116A0/xx unknown
- 1999-09-24 HU HU1300337A patent/HU229720B1/hu unknown
- 1999-09-24 ES ES10171553T patent/ES2408706T3/es not_active Expired - Lifetime
- 1999-09-24 CA CA2343929A patent/CA2343929C/en not_active Expired - Lifetime
- 1999-09-24 DK DK09004306.8T patent/DK2090583T3/da active
- 1999-09-24 EP EP99949923A patent/EP1115743B1/en not_active Expired - Lifetime
2001
- 2001-03-20 IL IL142116A patent/IL142116A/en not_active IP Right Cessation
- 2001-03-21 NO NO20011441A patent/NO329877B1/no not_active IP Right Cessation
2002
- 2002-01-18 HK HK02100390.4A patent/HK1040521A1/xx not_active IP Right Cessation
2009
- 2009-08-06 CY CY20091100835T patent/CY1110490T1/el unknown
- 2009-12-09 HK HK09111514.5A patent/HK1133021A1/xx not_active IP Right Cessation
2010
- 2010-03-25 NO NO20100442A patent/NO336685B1/no not_active IP Right Cessation
- 2010-06-23 JP JP2010142689A patent/JP4903886B2/ja not_active Expired - Lifetime
- 2010-11-07 IL IL209190A patent/IL209190A/en not_active IP Right Cessation
- 2010-11-07 IL IL209189A patent/IL209189A/en not_active IP Right Cessation
2011
- 2011-04-08 HK HK11103596.9A patent/HK1149279A1/xx not_active IP Right Cessation
- 2011-10-05 CY CY20111100947T patent/CY1112197T1/el unknown
2013
- 2013-04-15 CY CY20131100310T patent/CY1113932T1/el unknown

Also Published As

Publication number	Publication date
NO20011441D0 (no)	2001-03-21
IL209189A (en)	2017-11-30
AU757413B2 (en)	2003-02-20
EP1115743B1 (en)	2009-05-13
CA2794705C (en)	2017-07-18
CA2343929C (en)	2013-01-29
HUP0103889A2 (hu)	2002-03-28
JP2002525378A (ja)	2002-08-13
ATE431359T1 (de)	2009-05-15
IL209189A0 (en)	2011-01-31
HUP0103889A3 (en)	2004-03-01
NZ511020A (en)	2003-06-30
ES2408706T3 (es)	2013-06-21
IL142116A0 (en)	2002-03-10
DK2239269T3 (da)	2013-04-29
IL209190A0 (en)	2011-01-31
CY1110490T1 (el)	2015-04-29
EP2090583A1 (en)	2009-08-19
EP1115743A4 (en)	2005-04-27
SI1115743T1 (sl)	2010-01-29
ZA200102269B (en)	2002-03-19
NO20100442L (no)	2001-05-25
PT2239269E (pt)	2013-04-09
EP2090583B1 (en)	2011-07-13
HU229719B1 (en)	2014-05-28
JP4629229B2 (ja)	2011-02-09
CY1113932T1 (el)	2016-07-27
DK1115743T3 (da)	2009-07-27
PT1115743E (pt)	2009-07-07
NO336685B1 (no)	2015-10-19
IL142116A (en)	2010-12-30
HU229289B1 (en)	2013-10-28
CA2343929A1 (en)	2000-04-06
EP2239269A1 (en)	2010-10-13
WO2000018794A1 (en)	2000-04-06
ES2327301T3 (es)	2009-10-27
HK1040521A1 (en)	2002-06-14
CY1112197T1 (el)	2015-12-09
NO20011441L (no)	2001-05-25
HU229720B1 (en)	2014-05-28
CA2794705A1 (en)	2000-04-06
JP2010271325A (ja)	2010-12-02
ATE516297T1 (de)	2011-07-15
EP1115743A1 (en)	2001-07-18
EP2239269B1 (en)	2013-01-16
PT2090583E (pt)	2011-09-14
NO329877B1 (no)	2011-01-17
HK1149279A1 (en)	2011-09-30
HK1133021A1 (en)	2010-03-12
DE69940888D1 (de)	2009-06-25
JP4903886B2 (ja)	2012-03-28
AU6269599A (en)	2000-04-17
IL209190A (en)	2017-11-30
ES2369642T3 (es)	2011-12-02
DE09004306T1 (de)	2010-12-09

Publication	Publication Date	Title
DK2090583T3 (da)	2011-09-12	Copolymer 1-relaterede polypeptider til anvendelse som molekylvægtsmarkører og til terapeutisk anvendelse
DE68917183T2 (de)	1995-03-09	Elastisches Lager.
DE69630615D1 (de)	2003-12-11	Verwendung einer zusammensetzung enthaltend polyether block copolymere
DK641589D0 (da)	1989-12-18	N-aryl-azetidinoner, fremgangsmaade til deres fremstilling og deres anvendelse som elastaseinhibitorer
DK0579640T3 (da)	2002-11-11	Glialmitogene faktorer samt deres fremstilling og anvendelse
DE59201610D1 (de)	1995-04-13	Aktives, elastisches Lager.
DE3676859D1 (de)	1991-02-21	Kontinuierliches behandlungsverfahren fuer polymere zusammensetzungen.
NO862975L (no)	1987-01-26	Kvaternaere oksalkylerte polykondensater, fremgangsmaate til deres fremstilling, og deres anvendelse.
NO913035D0 (no)	1991-08-05	(2r)-2-(di(2-propyl)fosfonylmetoksy)-3-p-toluensulfonyloksy-1-trimetylacetoksypropan, fremgangsmaate for fremstilling og anvendelse derav.
NO900943D0 (no)	1990-02-28	Kopolymerer, fremgangsmaate for deres fremstilling og anvendelse.
NO862976L (no)	1987-01-26	Oksalkylerte polyesteraminer, fremgangsmaate til deres fremstilling, og deres anvendelse.
IT8521309A0 (it)	1985-06-26	Dispositivo e procedimento per sterilizzare articoli, in particolare strumenti chirurgici, strumenti odontotecnici e simili.
DE3777359D1 (de)	1992-04-16	Aminosaeuresequenz des menschlichen alpha 2-plasmininhibitors und cdns sowie diese aminosaeuresequenz codierende genomische dns.
NO911492L (no)	1991-04-16	Fremgangsmaate for aa detektere mark i kjoett.
DK564689D0 (da)	1989-11-10	Bacillus thuringiensisstammer og fremgangsmaade til fremstilling deraf, samt deres anvendelse som insekticider
NO884246D0 (no)	1988-09-26	Universalledd, eksempelvis til bruk som hofteledd.
IT8941774A0 (it)	1989-12-28	Base per sedie, poltroncine o simili
NO894682D0 (no)	1989-11-24	Liggeunderlag til bruk i sykeseng for pasienter med liggesaar, brannsaar eller lignende.
IT8921460A0 (it)	1989-08-04	Apparecchio per la correzione di malposizioni e/o la protezione delle arcate dentali.
IT8567379A1 (it)	1986-10-23	Composizioni polimeriche in particolare per usi agricoli.